Web Stats Provided By Google Analytics

Thursday, February 13, 2014

FDA Reviews Heart Failure Risk With Diabetes Drug Saxagliptin

The FDA has requested clinical trial data from Bristol-Myers Squibb, the manufacturer of saxagliptin , to investigate a possible association between the use of the type-2 diabetes drug and heart failure.

http://ift.tt/1eSZtcL

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts